CTSA Ansible – September 2020

THE SPOTLIGHT | WHAT’S NEW | GET INVOLVED | CONSORTIUM CORNER

Mike’s Blog – Will return in September 2020

THE SPOTLIGHT

Access to the COVID-19 Data Analytics Platform Now Open

Researchers studying COVID-19 now are able to access an innovative new analytics platform that contains clinical data from the electronic health records of people who were tested for the novel coronavirus or who have had related symptoms. Part of the NCATS National COVID Cohort Collaborative (N3C) Data Enclave, the centralized and secure data platform features powerful analytics capabilities for online discovery, visualization and collaboration. The data are robust in scale and scope and are transformed into a harmonized data set to help scientists study COVID 19, including potential risk factors, protective factors and long-term health consequences.

The N3C Data Enclave is anticipated to be one of the largest collections of data on COVID-19 patients in the United States. Data analysis within the enclave is supported by both R and Python, the most widely used open-source platforms for statistical analysis and data science (Watch a demonstration of the platform). Researchers requesting access to, or working within, the enclave are encouraged to assemble collaborative teams with diverse expertise in such areas as clinical research, statistical analysis and informatics to make the best use of the N3C Data Enclave.

Researchers interested in accessing the data will need to register with N3C and submit a Data Use Request for review by the N3C Data Access Committee. Learn more about the process and requirements, including data security training, for data access.

For More Information
>

WHAT’S NEW

Reserve Your Virtual Seat Now!

Meeting Theme: Diversity, Equity and Inclusion – Approaches and Solutions in Translational Science

“They need to know that everything will be ok. It’s so easy to focus on all of the challenges and to think it will not be, but in every generation, we go through periods of challenge, what’s most important is the power of the human spirit to transcend those challenges.” ~ Freeman A. Hrabowski III

Schedule at a Glance:
Administrators Group Meeting: November 17th, 11am – 2pm ET
CTSA Program Steering Committee Meeting: November 18th, 12 – 6pm ET
CTSA Program Meeting: November 19th and 20th, 11am – 5pm ET
Networking and Poster Session: November 20, 2020 – TBD

Meeting Highlights:Twitter handle: #2020CTSAProgramMtg
Have any questions? Click here to access CTSA Program Virtual Meeting FAQs
For additional assistance, contact us at program_meetings@clic-ctsa.org.

For More Information >

Seeking New Steering Committee Members

NCATS is seeking nominations for new CTSA Program Steering Committee (SC) members! We are seeking 3 UL1 PIs to serve on the committee for the next 3 years. If you would like to self-nominate or suggest a fellow PI, please submit the PI name, institution, and brief explanation (no longer than 1 paragraph)

Samantha.Jonson by Friday, October 2.

The eligibility criteria for SC appointments are as follows:

A PI must be officially named in the Notice of Grant Award of an active CTSA Program hub.
- An “active” award is defined as a hub award that is not in a
  No-Cost Extension (NCE). A PI whose hub award in an NCE is not considered eligible as there is insufficient time remaining in the award project period for initiation of an appointment.
The PI’s hub award must have at least 3 years remaining during the project period
The PI has not served on the SC since December 2014. At the time the SC was reorganized in 2014, NCATS made a commitment to the consortium that all funded and eligible PIs will have the opportunity to serve 1 term before second-term appointments.

For More Information >

2020 NCATS Responsive Un-Meeting – Save your spot!

This NCATS “rapid-response” Un-Meeting will encourage discussions around the changes encountered in the area of clinical and translational research resulting from the COVID pandemic. Other potential topics include Identifying clinical research trial design opportunities as a unified network in the post-COVID clinical era? What does training look like? What do remote trials look like? What is the impact on recruitment? Furthermore, what is the role of CTSA Program in clinical research post-COVID. We look forward to seeing you in the ether!
For More Information >

2021 Working Group Proposals

The CTSA Program Steering Committee is now accepting the first round (Cycle I) of proposals for

2021 Working Groups. As a reminder the Guidance for CTSA Program Groups states “A maximum of 12 active WGs will be supported by the CTSA Program Coordinating Center across the consortium at any given time with a target of ≤ 2 from a specific EC“. If you wish to submit a CTSA Program Working Group proposal that is to be associated with an Enterprise Committee, please make sure that it is approved by the EC Lead Team prior to submission. To submit a proposal, please log on to the CLIC website and complete this form (login required). Groups or individuals interested in forming a Working Group are required to propose and deliver well-defined projects or deliverables that fill identified translational gaps and/or further the CTSA Program objectives in high priority areas within clinical and translational science.

Any group or individual within the CTSA Program is eligible to submit an application for a Working Group. Working Groups that are approved by the CTSA Program Steering Committee will be supported by CLIC. The deadline to submit a 2021 Cycle I CTSA Working Group proposal is Wednesday, September. 30, 2020.

For More Information >

Notices and Administrative Supplements – Fall 2020

RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) ( RFA-OD-20-023)

Due Date: September 30, 2020
NICHD POC (Point of Contact): Bill G. Kapogiannis, MD
NCATS POC:Joan Nagel, MD, MPH and Mary Purucker, MD, PhD

CTSA Program: Diversity and Re-Entry Supplements

Due Date: November 1, 2020
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed) PA-20-022
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp – Clinical Trial Not Allowed) PA-18-592 (may be updated soon)
NOTE: all administrative supplements are required to be submitted electronically NOT-OD-20-128
CTSA Program-Specific Guidance for Diversity and Re-Entry Research Supplements
POC: Xinzhi Zhang, MD, PhD (or your Program Officer)

Notice of Special Interest: NCCIH Administrative Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development ( NOT-AT-20-010)

Due Date: October 1, 2020
POCs: Lanay M. Mudd, Ph.D. National Center for Complementary and Integrative Health (NCCIH) and Carol Merchant, M.D., MPH National Center for Advancing Translational Sciences (NCATS)

Notice of Change to Key Dates for PAR-18-940 “Clinical and Translational Science Award (U54 Clinical Trial Optional)”

NOT-TR-20-036
The purpose of this notice is to inform interested applicants in a change to the Key Dates for PAR-18-940 “Clinical and Translational Science Award (U54 Clinical Trial Optional)”. The August 15, 2021 receipt date has been moved to July 15, 2021.